Spacetalk (ASX:SPA) - CEO & Managing Director, Simon Crowther
CEO & Managing Director, Simon Crowther
Source: Simon Crowther/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Spacetalk (SPA) raises $760,000 through a placement to professional and sophisticated investors
  • The placement comprised the issuance of 34 million new shares at 2.2 cents each
  • SPA announces a rights issue to raise additional capital
  • placement participants will receive one option for every two new shares subscribed for, subject to SPA shareholders
  • SPA shares last traded at 2.1 cents

Spacetalk (SPA) has completed an equity raising of $760,000 through a placement to professional and sophisticated investors.

The placement comprised the issuance of 34 million new shares at 2.2 cents each.

The company also announced a partially underwritten non-renounceable rights issue on a 1-for-2.5 basis to raise additional capital to offer working capital and capital to support short-term strategic initiatives.

“We are delighted that our shareholders have chosen to support Spacetalk with significant investments via a single-tranche placement,” SPA CEO and Managing Director Simon Crowther said.

“This is a strong show of faith in our leadership team and our strategy.

“We look forward to continuing to execute and demonstrating progress to all our investors.”

Additionally, placement participants will receive one option for every two new shares subscribed for, subject to SPA shareholders.

Veritas Securities acted as the lead manager for the placement and will continue to serve in the rights issue.

SPA shares last traded at 2.1 cents.

SPA by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next